Batch Notification Number |
BN-OL-2022-07-28-3869
|
FDA Registered Product/Generic Name |
Polymyxin B (as Sulfate) + Neomycin (as Sulfate) + Dexamethasone Sodium Phosphate
|
Brand Name |
Maxoptic
|
Dosage Strength |
6,000 Units/ 5 mg/ 1 mg per mL
|
Dosage Form |
Solution Ophthalmic
|
Registration Number |
DRP-687
|
Batch Number |
N/A
|
Lot Number |
2A39A
|
Product Expiration Date |
May 2024
|
Issuance Date |
28 July 2022
|